Table 3.

Results from studies in the literature reporting on mucin phenotypes based on immunohistochemical mucin stains

Author	Year	Number SRC-GC		Description SRC-GC	Classification tumour type used	Mucin phenotypes (% of total SRC-GCa)				Relationship with survival	Comparison with other tumour types
		n	%			G	I	GI/mixed	U		Yes/No
Bamba M	2001	54	100	Yes	JGCA	28	2	69	NA	Yes	No
Tsukashita S	2003	17	17	No	NR	77	0	0	23	NR	Yes
Aihara R	2004	69	100	Yes	WHOb, JGCA	60	0	41	0	Yes	No
Aihara R	2005	69	54	Yes	WHOb	47	2	46	5	Yes	Yes
Ohkura Y	2005	79	28	No	No	SRC: 81; mixed: 35	SRC: 2; mixed: 15	SRC: 16; mixed: 50	0	NR	No
Tian MM	2007	66	100	Yes	WHOc	26	15	47	12	Yes	No
Nakajima T	2016	35	100	No	No	0	0	35	0	NR	No
Xiong ZF	2017	163	100	Yes	No	39	18	42	NA	Yes	No

n number of cases, % percentage of all cases, G gastric phenotype, I intestinal phenotype, GI gastrointestinal phenotype, U unclassified, NA not applicable, NR not reported, SRC signet-ring cell, GC gastric cancer, WHO World Health Organisation, JGCA Japanese Gastric Cancer Association

^aPercentages rounded up

^b2nd edition WHO

^c3rd edition WHO